StonvexLoading…
StonvexCore line items from DE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-11-02 | Annual 2024 2024-10-27 | Annual 2023 2023-10-29 | Annual 2022 2022-10-30 |
|---|---|---|---|---|
Revenue | $45.68B | $51.72B | $61.25B | $52.58B |
Operating Income | $6.26B | $9.04B | $12.96B | $9.51B |
Net Income | $5.03B | $7.10B | $10.17B | $7.13B |
EPS (Diluted) | $18.50 | $25.62 | $34.63 | $23.28 |
Total Assets | $106.00B | $107.32B | $104.09B | $90.03B |
Total Liabilities | $79.99B | $84.39B | $82.20B | $69.67B |
Cash & Equivalents | $8.28B | $7.32B | $7.46B | $4.77B |
Free Cash Flow OCF − CapEx | $6.10B | $7.59B | $7.09B | $3.56B |
Shares Outstanding | 270.40M | 271.80M | 281.60M | 306.30M |